[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Publications found: 1,146
Sort by:

Stem Cell Therapy-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Stem Cell Therapy-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detaile...

February 2018 131 pages

Stem Cell Therapy-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Stem Cell Therapy-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detailed marke...

February 2018 139 pages

Stem Cell Therapy-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Stem Cell Therapy-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detailed market...

February 2018 130 pages

Stem Cell Therapy-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Stem Cell Therapy-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detailed mark...

February 2018 158 pages

Stem Cell Therapy-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Stem Cell Therapy-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detailed mark...

February 2018 138 pages

Stem Cell Therapy-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

Report Stem Cell Therapy-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, deli...

February 2018 150 pages

Stem Cell Therapy-India Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Stem Cell Therapy-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detailed marke...

February 2018 152 pages

Stem Cell Therapy-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Stem Cell Therapy-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detail...

February 2018 150 pages

Stem Cell Therapy-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Stem Cell Therapy-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detail...

February 2018 138 pages

Stem Cell Therapy-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Stem Cell Therapy-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Stem Cell Therapy industry, standing on the readers? perspective, delivering detail...

February 2018 134 pages

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2018

US$ 3,500.00

... Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 45 pages

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) development landscape Develop and ...

February 2018 54 pages

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) - Pipeline Review, H1 2018

US$ 3,500.00

... reviews key players involved in Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) targeted therapeutics development with respective ...

February 2018 35 pages

E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2018

US$ 3,500.00

... /Universities. It also reviews key players involved in E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) targeted therapeutics development with respective active ...

February 2018 74 pages

Raynauds Disease - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Raynauds Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Raynauds Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

February 2018 50 pages

Japan Proton Therapy Market Research Report 2018

US$ 1,100.00

... ) Japan Proton Therapy Reimbursement Scenario Proton Therapy Center Component Analysis Proton Therapy Clinical Trail Insight by Phase, Institute & Country Proton Therapy Market – Major Deals Key Market Drivers and Inhibitors of the Japan Proton Therapy Market ...

February 2018 110 pages

Testosterone Replacement Therapy (TRT): Market Research Report

US$ 5,600.00

This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The Global and US markets are further analyzed by the following Product Segments: ... , a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...

January 2018 203 pages

Fibromyalgia Therapeutics: Market Research Report

US$ 5,450.00

This report analyzes the Global market for Fibromyalgia Therapeutics in US$ Million. Annual estimates and forecasts are provided for the ... 2022. Also, a six-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary ...

January 2018 78 pages

Acute Myeloid Leukemia (AML) Therapeutics: Market Research Report

US$ 5,450.00

This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the ... players such as - Bayer AG Bristol-Myers Squibb Company Cardiorentis AG CVie Therapeutics Limited Cytokinetics, Inc.

January 2018 156 pages

Targeted Therapies in Asthma: KOL Insight [2018]

US$ 8,495.00

... how developers can differentiate their pipeline therapies in KOL Insight: Targeted Therapies in Asthma. Ten North American and European KOLs provide their insight on 3 marketed products and ...

January 2018

General Anxiety Disorder Therapeutics-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the Asia Pacific General Anxiety Disorder Therapeutics market as: Asia Pacific General Anxiety Disorder Therapeutics Market: Regional Segment ...

January 2018 131 pages

General Anxiety Disorder Therapeutics-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... General Anxiety Disorder Therapeutics by types and applications Cost and profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the China General Anxiety Disorder Therapeutics market as: China General Anxiety Disorder Therapeutics ...

January 2018 159 pages

General Anxiety Disorder Therapeutics-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary General Anxiety Disorder Therapeutics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on General Anxiety Disorder Therapeutics industry, standing on the readers’ perspective, delivering detailed market data ...

January 2018 147 pages

General Anxiety Disorder Therapeutics-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Anxiety Disorder Therapeutics by types and applications Cost and profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the Europe General Anxiety Disorder Therapeutics market as: Europe General Anxiety Disorder Therapeutics Market ...

January 2018 132 pages

General Anxiety Disorder Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... General Anxiety Disorder Therapeutics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on General Anxiety Disorder Therapeutics industry, standing on the readers’ perspective, delivering detailed market ...

January 2018 147 pages

General Anxiety Disorder Therapeutics-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary General Anxiety Disorder Therapeutics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on General Anxiety Disorder Therapeutics industry, standing on the readers’ perspective, delivering detailed market data ...

January 2018 147 pages

General Anxiety Disorder Therapeutics-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... General Anxiety Disorder Therapeutics by types and applications Cost and profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the India General Anxiety Disorder Therapeutics market as: India General Anxiety Disorder Therapeutics ...

January 2018 139 pages

General Anxiety Disorder Therapeutics-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the North America General Anxiety Disorder Therapeutics market as: North America General Anxiety Disorder Therapeutics Market: Regional Segment ...

January 2018 147 pages

General Anxiety Disorder Therapeutics-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the South America General Anxiety Disorder Therapeutics market as: South America General Anxiety Disorder Therapeutics Market: Regional Segment ...

January 2018 141 pages

General Anxiety Disorder Therapeutics-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... profit status of General Anxiety Disorder Therapeutics, and marketing status Market growth drivers and challenges The report segments the United States General Anxiety Disorder Therapeutics market as: United States General Anxiety Disorder Therapeutics Market: Regional Segment ...

January 2018 138 pages

Constipation - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Constipation (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Constipation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

January 2018 117 pages

Primary Biliary Cirrhosis - Pipeline Review, H1 2018

US$ 2,000.00

... releases. The Primary Biliary Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Biliary Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2018 111 pages

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) development landscape Develop and design in-licensing ...

January 2018 35 pages

Cluster Headache Syndrome - Pipeline Review, H1 2018

US$ 2,000.00

... . The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...

January 2018 49 pages

Encephalitis - Pipeline Review, H1 2018

US$ 2,000.00

... . The Encephalitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2018 34 pages

Global Proton Therapy Market Outlook 2022

US$ 1,050.00

... industry. The report “Global Proton Therapy Market Outlook 2022” provides an in-depth analysis of the current scenario, detailed market outlook of global proton therapy market. The report provides detailed proton therapy market assessment across major ...

January 2018 98 pages

Pulmonary Arterial Hypertension (PAH) Therapeutics: Market Research Report

US$ 5,450.00

This report analyzes the worldwide markets for Pulmonary Arterial Hypertension (PAH) Therapeutics in US$ Million. The Global market is analyzed by the following Drug Class ... Pharmaceuticals Ltd. Bayer AG Gilead Sciences, Inc. Pfizer, Inc. United Therapeutics Corporation

December 2017 161 pages

Peripheral Arterial Disease (PAD) Therapeutics: Market Research Report

US$ 5,450.00

This report analyzes the worldwide markets for Peripheral Arterial Disease (PAD) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... HealthCare Pharmaceuticals Bristol-Myers Squibb Company Merck & Co., Inc. Proteon Therapeutics, Inc.

December 2017 136 pages

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics: Market Research Report

US$ 5,450.00

This report analyzes the worldwide markets for Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics in US$ Million. The report provides separate comprehensive analytics for ...

December 2017 120 pages

Global CAR T Cell Therapy Market (By Targeted antigen – HER1, HER2, CD19, CD20, CD22, CD30, CD33, GD2, MESO and EGFRvIII, By Treatment - Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Acute Myeloid Leukemia (AML), Breast Cancer, Pancreatic Cancer, Neuroblastoma (NB), Colon Cancer And Hepatocellular Carcinoma (HCC)) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025

US$ 4,795.00

... an inclusive study of the global CAR T cell therapy market. The report provides the size of the global CAR T cell therapy market from 2017 and the ... and Celgene Corporation among others. The global CAR T cell therapy market has been segmented into: Global CAR T Cell Therapy Market: By Targeted Antigen HER1 HER2 ...

December 2017 139 pages

2018-2023 Asia and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Asia Retinal Vein Occlusion Therapeutics Market Research has the complete assessment of ... future outlook and prospects for Retinal Vein Occlusion Therapeutics market. This report focus on Asia and regional market, providing information on major players ...

December 2017 156 pages

2018-2023 China and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the China Retinal Vein Occlusion Therapeutics Market Research has the complete assessment of ... future outlook and prospects for Retinal Vein Occlusion Therapeutics market. This report focus on China and regional market, providing information on major players ...

December 2017 140 pages

2018-2023 Europe and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Europe Retinal Vein Occlusion Therapeutics Market Research has the complete assessment of ... future outlook and prospects for Retinal Vein Occlusion Therapeutics market. This report focus on Europe and regional market, providing information on major players ...

December 2017 186 pages

2018-2023 North America and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the North America Retinal Vein Occlusion Therapeutics Market Research has the complete ... for Retinal Vein Occlusion Therapeutics market. This report focus on North America and regional market, providing information on major players like manufacturers, suppliers ...

December 2017 151 pages

2018-2023 South America and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the South America Retinal Vein Occlusion Therapeutics Market Research has the complete ... for Retinal Vein Occlusion Therapeutics market. This report focus on South America and regional market, providing information on major players like manufacturers, suppliers ...

December 2017 195 pages

2018-2023 Southeast Asia and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the Southeast Asia Retinal Vein Occlusion Therapeutics Market Research has the complete ... for Retinal Vein Occlusion Therapeutics market. This report focus on Southeast Asia and regional market, providing information on major players like manufacturers, suppliers ...

December 2017 183 pages

2018-2023 United States and Regional Retinal Vein Occlusion Therapeutics Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

US$ 3,500.00

The recent report from HNY RESEARCH on the United States Retinal Vein Occlusion Therapeutics Market Research has the complete ... for Retinal Vein Occlusion Therapeutics market. This report focus on United States and regional market, providing information on major players like manufacturers, suppliers ...

December 2017 179 pages

E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) development landscape Develop and ...

December 2017 75 pages

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) - Pipeline Review, H2 2017

US$ 3,500.00

... Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 48 pages

Filters

Search

Publishers

23
1
97
2
21
16
2
2
2
3
8
1
1
1
6
126
1
1
2
10
8
1
22
8
2
2
1
70
3
2
21
2
4
1
2
2
6
10
8
1
9
2
1
3
1
1
4
22
6
2
3
1
15
18
6
1
2
18
17
1
2
5
1
19
33
19
27
19
5
324
17
16
2
4
1
17

Regions

1
1
1
2
1
2
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
2
10
1
17
14
2
1
2
1
13
3
3
1
2
1
1
1
2
2
2
1
2
21
1
1
2
12
10
4
31
943
1

Price

Date

Pages

Offers

97
21
5
1